Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 - Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
April 23, 2024 03:54 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Cannabis Capsule Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The cannabis capsule market size has grown...
United States Cannabinoids Market Report 2022: A $60+ Billion by 2030 - Rising Number of New Players, Leading to Expansion
August 30, 2022 05:58 ET
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "U.S. Cannabinoids Market Size, Share & Trends Analysis Report by Product (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG),...
United States Minor Cannabinoids Market Report 2021: Market is Expected to Reach $26.2 Billion by 2028, at a CAGR of Over 20%
January 11, 2022 07:23 ET
|
Research and Markets
Dublin, Jan. 11, 2022 (GLOBE NEWSWIRE) -- The "U.S. Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management,...
Global Medical Marijuana Cannabidiol Pipeline Report 2021 Featuring Bionorica SE, Corbus Pharmaceuticals, Therapix Biosciences, TO Pharmaceuticals, Canbex Therapeutics & InMed Pharma
October 25, 2021 05:33 ET
|
Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Medical Marijuana - Cannabidiol - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. "Medical Marijuana -...
InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference
August 12, 2021 12:00 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company developing cannabinoid-based...
InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with IntegraSyn™ in Advance of Commercial Scale Production
June 17, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
5 g/L cannabinoid yield significantly exceeds reported industry yieldsSignificantly reduces the overall cost of rare cannabinoid manufacturingContinued advancement to GMP-ready large-scale batch...
InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
April 28, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
Filings submitted in Austria, Israel, and Serbia for a Phase 2 Clinical Trial with INM-755 creamAdditional submissions slated for France, Germany, Greece, and Italy over the next several days and...
Global Medical Cannabis Market Insights, Analysis and Forecasts Report 2020-2025 Featuring TEVA, Cannabis Science, Gb Sciences, Akorn, Cronos Group Among Others
December 21, 2020 10:28 ET
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Medical Cannabis Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Product Type" report has been added...
MCTC Expands R&D Program to Include Producing Polymeric Nanoparticles of Valuable, Hard-to-Obtain Cannabinoids
November 20, 2019 07:30 ET
|
MCTC Holdings Inc. (d/b/a Cannabis Global)
LOS ANGELES, Nov. 20, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – MCTC Holdings Inc. (OTC: MCTC) today announces an expanded R&D program designed to produce polymeric nanoparticles of cannabinol...
Cannabis Science Set to Integrate Its Sponsored Research In Nigeria to Include Its U.S. Patent Number 9,763,991 for Compositions of Cannabinol (CBN) for Treatment of Various Neurological Conditions
February 25, 2019 07:28 ET
|
Cannabis Science, Inc.
IRVINE, CA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Pre-Clinical Work and Animal Studies Underway, and Protocols for Clinical Studies Under Development via NEWMEDIAWIRE -- Cannabis Science, Inc....